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 Abstract
Objectives: The study was designed to determine the accuracy of using systolic (SBP) and diastolic blood pressure 
(DBP), mean arterial pressure (MAP), and increase of blood pressure (BP) to predict Preeclampsia (PE). 
Materials and Methods: We examined 300 normotensive and 100 PE pregnancies divided in two subgroups: 
mild (n=67) and severe (n=33) PE. The patients had a BP check in first and second trimester (SBP, DBP, and 
MAP). 
Results: We found out significant difference between the groups, but what is more important is that the difference 
in BP values (especially diastolic and MAP) existed before the pathological increase of the BP above the normal 
values. This was happening most often after 31 wg (at 92.5%) and less often after 26 wg (at 7.5%) at the pregnancies 
with mild PE while at the pregnancies with severe PE, 18,2% had increased tension after 21 wg; 24% in the period 
of 26-30 wg and 57.58% after 31 wg. 
Conclusion: Based on the results we could conclude that when BP is measured in the first or second trimester of 
pregnancy, the MAP is a better predictor for PE than SBP and DBP. 
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Introduction
Preeclampsia	 (PE)	 is	 a	 multisystem	 disorder	 of	 unknown	
aetiology, unique	to	pregnancy.	Women	with	PE	usually	develop 
raised	blood	pressure	after	20	weeks	of	gestation,	but	the	condition	
is also	associated	with	abnormalities	of	the	coagulation	system, 
disturbed	 liver	 function,	 renal	 failure	and	cerebral	 ischemia	 [1,	
2]. It	 complicates	 an	 estimated	 2–30%	 of	 pregnancies	 and	 is a 
major	cause	of	maternal	morbidity,	prenatal	death	and	premature 
delivery,	although	for	most	women	the	outcome	is	good	[3-5].	
The	 pathogenesis	 of	 preeclampsia	 is	 complex.	 It	 has	 been	
suggested	that	preeclampsia	is	a	two-stage	disease	[6]:	Stage	1:	
asymptomatic,	characterized	by	abnormal	placental	development	
during	 the	 first	 trimester	 resulting	 in	 placental	 insufficiency.	
This	in	turn	leads	to	symptomatic,	stage	2,	wherein	the	pregnant	
women	develops	characteristic	hypertension,	 renal	 impairment,	
and	proteinuiria	and	is	at	risk	for	the	HELLP	syndrome,	eclampsia	
and	other	endorgan	damage	[6,	7].
The PE	 is	 associated	 with	 low	 birth	 weight	 and	 preterm	
delivery, but	 can	 also	 develop	 at	 term,	 during	 labour,	 or	 even	
post	partum. It	has	been	shown	that	women	destined	to	develop	
pre-eclampsia have	higher	mean	arterial	pressures	in	the	first	and	
second trimester	 and	 even	 before	 pregnancy	 than	women	with	
normal	pregnancies	[8,	9].	
Women	with	PE	generally	have	a	good outcome.	The	risks	to	
them	and	their	baby	increase	only	if	they	progress	to	PE,	or	have	
very	high	blood	pressure	[9,	10]. 
Objectives
Blood	pressure	(BP)	measurement	is	a	screening	test	routinely	
used in	antenatal	care	 to	detect	or	predict	hypertensive	disease.	
Studies	investigating	the	predictive	accuracy	of	BP	measurement	
report	conflicting	results.	In	view	of these	conflicting	reports	it	is	
uncertain	whether	BP measurement	should	be	used	routinely	as	
a	predictive	test	or should	only	be	used	to	diagnose	hypertensive	
disorders	in	pregnancy	once they	are	suspected.	The	aim	of	this	
study	is	to	examine	the	performance	of	screening	for	PE	and	to	
compare	systolic	BP	(SBP),	diastolic	BP	(DBP),	and	mean	arterial	
pressure	 (MAP)	 measured	 by	 validated	 devices	 in	 pregnant	
women.
Materials and Methods
The	 research	 was	 conducted	 in	 the	 Clinical	 Hospital	 ”Dr	
Trifun	Panovski”	 in	Bitola,	Macedonia	 (FYROM),	Department	
of	gynaecology	and	obstetrics.	These	patients	had	been	admitted	
during	 the	 period	 of	 May	 1st	 2008	 to	August	 1st	 2009.	 This	
study	protocol	was	approved	by	the	Director	of	Clinical	Hospital	
in	 Bitola,	 and	 the	 Ethics	 committee	 of	 School	 of	 Medicine	
University	of	Belgrade,	Serbia.	A	written	consent	was	provided	
by	all	participants.	The	research	was	conducted	in	the	Antenatal	
Care	 Ambulance	 which	 is	 part	 of	 the	 Gynecology-Obstetric	
Department.	Approximately,	 this	ambulance	provides	 treatment	
to	900-1000	patients	annually,	while	at	the	Gynecology-Obstetric	
Department	 approximately	 1600	 pregnancies	 are	 delivered	
annually.	
The	 study	 included	 400	 participants.	 Considering	 the	
recommendations	of	the	Ethics	committee,	this	prospective	study	
is	 based	on	300	normotensive	pregnants	 and	100	preeclamptic	
pregnants.
The	 preeclamptic	 women	 later	 on,	 based	 on	 clinic	 and	
laboratory	parameters,	were	divided	 in	 two	 subgroups:	women	
with	mild	and	severe	preeclampsia.	This	study	wasn’t	limited	by	
any	 timelines	and	when	we	 reached	 the	demanded	numbers	of	
patients,	we	concluded	the	research.	
The	research	was	conditioned	with	the	following	criteria:
The	criteria	to	determine	the	exact	pregnancy	stage	is	based	
on	the	following	criteria:	anamnestical,	obstetrical	and	ultrasound	
scan,	 which	 means	 that	 the	 information	 of	 the	 last	 period	 is	
corresponding	with	the	results	from	the	obstetrical	examination	
and	the	ultrasound	scan.	The	first	examination	was	performed	in	
the	period	of	6-12	week	of	gestation	(wg).	
The	participants	were	healthy	women	with	normal	BP	 (on	
their	 first	 visit	 they	 didn’t	 have	 artery	 pressure	 above	 120/80	
mmHg),	with	no	history	of	any	chronic	disease,	with	singleton	
pregnancy,	 without	 chromosomal	 or	 congenital	 abnormalities,	
with	exact	date	of	the	last	menstrual	period	and	regular	menstrual	
period.	
We	 reviewed	 age,	 parity,	 smoking	 status,	 week	 of	
preeclampsia	 onset,	 duration	 of	 preeclapmpsia,	 duration	 of	
pregnancy,	 and	 birth	weight	 in	 percentile.	 Smoking	 status	 and	
level	of	education	was	determined	by	self-report.	
 Streszczenie
Cel pracy: Ocena przydatności pomiarów ciśnienia skurczowego (SBP) i rozkurczowego (DBP), średniego ciśnienia 
tętniczego (MAP) i wzrostu ciśnienia tętniczego (BP) w przewidywaniu stanu przedrzucawkowego.
Materiał i metody: Zbadano 300 ciężarnych z prawidłowym ciśnieniem tętniczym oraz 100 ze stanem 
przedrzucawkowym, które podzielono na dwie podgrupy: z łagodnym i ciężkim stanem przedrzucawkowym. 
Pacjentkom mierzono ciśnienie tętnicze w I i II trymestrze ciąży (SBP, DBP i MAP).
Wyniki: Znaleziono istotne różnice pomiędzy badanymi grupami. Co więcej różnica wartości ciśnienia rozkurczowego 
i średniego ciśnienia tętniczego istniała już przed patologicznym wzrostem ciśnienia powyżej wartości prawidłowych. 
W ciążach z łagodnym stanem przedrzucawkowym najczęściej zaburzenie to występowało po 31 tyg. ciąży 
(92,5%), najrzadziej po 26 t.c.(7,5%). Podczas gdy w przypadkach z ciężkim stanem przedrzucawkowym, 18,2% 
miało podwyższone ciśnienie po 21 t.c., 24% w okresie 26-30 t.c. a 57,58% po 31 t.c. 
Wnioski: W oparciu o wyniki naszej analizy można powiedzieć, że MAP jest lepszym predykatorem stanu 
przedrzucawkowego niż SBP czy DBP.
 Słowa kluczowe: stan przerzucawkowy / predykcja / ciśnienie tętnicze / 
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All	subjects	were	followed	until	delivery.	The	gestational	age	
at	delivery,	obstetric	complications	if	any,	and	neonatal	outcome	
were	 recorded.	 For	 those	 subjects	 who	 were	 subsequently	
delivered	 in	 another	 hospital,	 the	 obstetric	 information	 was	
obtained	by	telephoning	the	subject	or	via	contact	with	the	staff	in	
the	other	hospital.	Birth	weight	(to	the	nearest	gram)	was	classified	
into	five	categories:	very	low	birth	weight	(<5th	percentile),	low	
(5-9,9),	 normal	 (10-89.9),	 high	 (90-94.9)	 and	 very	 high	 (>95).	
Intrauterine	growth	restriction	(IUGR)	is	defined	as	birth	weight	
less	 than	 the	 10th	 percentile	 based	 on	 the	 Alexander	 growth	
standard	[11].
Pre-pregnancy	 or	 at	 booking	 body	mass	 index	 (BMI)	was	
based	on	measured	height	and	maternal	weight	at	the	initial	visit	
(6-12	 w.g.)	 and	 maternal	 self	 report	 of	 pre-pregnancy	 weight.	
Height	was	measured	by	using	a	portable	stadiometer,	accurate	
to	1	mm.	Pre-pregnancy	BMI	was	categorized	as:	underweight	
(<19.9),	 normal	 (20.0-24.9),	 overweight	 (25.0-29.9)	 or	 obese	
(>30.0)	[12].	Total	maternal	weight	gain	during	pregnancy	was	
recorded	on	admission	to	delivery	ward.	
BP	 measurements	 were	 performed	 using	 a	 mercury	
sphygmomanometer according	 to	 a	 standardized	 published	
protocol,	 and	 all urine	 specimens	were	 assessed	 for	 protein	 by	
dipstick.	MAP	(in	mmHg)	was	calculated	using	 the	equitation:	
MAP=	(SBP+	2xDBP)/3	[13].
Mild	PE	was	defined	by	the	occurrence	of	two	or	more	SBP	
≥140mmHg	and/or	DBP	≥90mmHg,	with	 the	first	 elevated	BP	
occurring after	20	weeks’	gestation	up	to	24	hours	after	delivery	
[14]. 
Severe	 PE	 was	 defined as	 a	 SBP	 ≥160mmHg	 and	 DBP	
≥110mmHg	on	 at	 least two	 occasions	 at	 least	 4	 hours	 apart	 or	
on	 one	 occasion	 if	 antihypertensive therapy	 was	 administered.	
Severe	 proteinuria was	 defined	 with	 a	 24-hour	 urine	 sample	
containing	≥3.5	g of	protein	or	two	urine	samples	of	“3+	protein”	
or	greater	taken	at	least	4	hours	apart	[14]. 
During	 the	 research	 the	 methods	 used	 were	 descriptive	
statistics,	 the	relative	numbers,	chi-quadrate	test,	Student	t-test,	
multivariate	 analysis	 and	 post-hoc	 test	 was	 used	 to	 determine	
the	statistical	differences	between	groups.	A	p	value	<0.05	was	
considered	statistically	significant.	
Table I. Description of maternal characteristics and pregnancy outcome by study groups.  
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Results
Table	1	shows	the	demographic	and	clinical	characteristics	
of	the	women	studied.	The	significant	difference	in	the	frequency	
of	 categories	 and	 age	 groups	 was	 tested	 with	 a	 method	 of	
multivariate	 analysis	 for	 proportion.	 The	 difference	 was	 not	
statistically	 significant	 p>0.05,	 which	 clearly	 shows	 that	 the	
groups	are	a	priori	similar	and	comparable.	
The	significant	difference	in	the	frequency	of	categories	and	
parity	groups	was	tested	with	a	method	of	multivariate	analysis	
for	proportion.	The	difference	was	statistically	significant	p<0.05.	
We	found	a	decreased	risk	of	mild	and	severe	PE	among	women	
who	smoked	during	pregnancy.	
Women	 who	 developed	 preeclampsia	 had	 higher	 rates	 of	
overweight	 prior	 to	 pregnancy	 and	gained	more	weight	 during	
pregnancy.	The	majority	of	women	who	developed	preeclampsia	
were	overweight,	but	not	obese	(p<0.01).
The	newborns	from	the	hypertensive	pregnancies	had	lower	
birth	weight	vs.	neonates	from	normotensive	pregnancies.	
The	severe	vs.	mild	PE,	occurs	earlier	in	pregnancy	30.4±4.5	
(21-38	w.g.)	vs.	34.5±2.7	 (26-38)	and	 the	hypertension	 is	 long	
lasting	(8.0±4.3	vs.	4.8±2.6).	Early	beginning	of	the	hypertension	
during	the	pregnancy	is	associated	with	longer	lasting	and	more	
severe	conditions	of	PE.	Early	development	of	hypertension	 is	
also	associated	with	more	severe	conditions	of	PE.	The	 results	
are	presented	in	Table	II.
Table II. Characteristics of mild and severe preeclampsia.  
Table III. Values of systolic blood pressure, diastolic blood pressure and mean arterial pressure.  
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During	the	regular	checkups	every	patient	had	BP	measured.	
Table	III	shows	the	results	of	measured	systolic	(SBP),	diastolic	
pressure	(DBP)	and	mean	arterial	pressure	(MAP)	in	the	following	
periods:	8-12,	13-16,	17-20,	25-27	week	of	gestation	(w.g.)	and	
postpartal	values	maximum	one	week	postpartum.	
Here	 we	 found	 that	 statistical	 difference	 between	 groups,	
before	 pathological	 increase	 of	 pressure	 exists	 (p<0,05).	 Both	
DBP	and	MAP	were	significantly	higher	in	the	first	and	second	
trimester	for	pregnants	who	later	developed	PE.
Discussion
Preeclampsia	 is	 a	 major	 cause	 of	 maternal	 and	 neonatal	
morbidity	and	mortality	worldwide.	Some	studies	are	concluding	
that	 the	major	 phenotype	 of	 PE,	 hypertension	 and	 proteinuria,	
may	be	due	 to	an	excess	of	 circulating	anti-angiogenic	growth	
factors,	most	notably	soluble	 fms-like	 tyrosine	kinase	1	 (sFlt1)	
and	soluble	endoglin	(sEng)	[15,	16].
Generally,	 to	 identify	 particular	 potential	 factors	 in	 cases	
of	PE	in	some	population	requires	a	lot	of	effort.	Some	factors	
have	 proven	 cause	 connection	 for	 PE;	 however	 at	most	 of	 the	
cases	we	couldn’t	prove	any	connection.	The	main	focus	of	PE	
and	 its	 symptomatology	 is	 the	hypertension.	Diastolic	pressure	
as	 a	 relation	 to	 arteriolar	 spasm	 is	 a	 permanent	 damage	of	 the	
blood	circulation	and	has	primary	 influence.	Values	of	 systolic	
pressure	are	affecting	the	vegetative	irritable,	reaction	for	external	
sensation	and	mental	perception	[17].
The	 importance	of	BP	measurement	during	pregnancy	has	
been	recognized	for	more	than	a	century	(Seligman,	1987)	and	
is	a	 fundamental	part	of	antenatal	care.	For	many	women	their	
pregnancy	will	be	the	first	point	of	medical	contact	and	they	may	
have	 been	 unaware	 of	 any	 pre-existing	 hypertension	 up	 to	 the	
third	point	[18].	
In	 the	 present	 study,	 the	 lower	 birth	weight	 and	 length	 at	
birth,	 underline	 the	 severity	 of	 the	 disease	 in	 the	 preeclamptic	
groups.	Also,	these	results,	too,	are	same	as	from	the	associated	
literature	in	this	area	[18,	19].
Our	study	includes	data	of	smoking	status.	It	is	well	known	
that	 smoking	 is	 a	 strong	and	common	 risk	 factor	 for	 low	birth	
weight.	 Smoking	 seems	 to	 be	 negatively	 associated	 with	 PE.	
Thus,	smoking	would	increase	rather	than	decrease	the	effect	of	
PE	in	infants’	size	[20].	
During	our	research	we	were	measuring	the	SBP	and	DBP	
and	calculating	the	MAP	during	the	pregnancy.	Based	on	the	BP	
measurements,	we	found	out	significant	difference	between	the	
group	of	hypertensive	and	normotensive	pregnancies,	but	what	
is	more	important	is	that	the	difference	in	BP	values	(especially	
diastolic	and	MAP)	existed	before	 the	pathological	 increase	of	
the	artery	pressure	above	the	normal	values.	This	was	happening	
most	often	after	31	wg	(at	92,54%).	
Based	 on	 the	 results	 that	 we	 got	 during	 our	 research	 we	
could	 conclude	 that	 in	 the	 first	 and	 the	 second	 trimester	 of	
pregnancy,	 MAP	 has	 higher	 predictability,	 while	 with	 SBP	
statistically	 significant	 difference	 is	 obvious	 with	 SP	 group	
related	pregnancies.	After	the	manifested	imbalance,	significant	
difference	between	the	groups	was	noticeable	at	the	DBP	values.	
SBP	has	the	lowest	predictable	values.	The	values	of	SBP	even	
before	the	PE	manifestation	at	the	hypertensive	pregnancies	are	
slightly	 higher	 than	 the	 measured	 values	 at	 the	 normotensive	
pregnancies;	however	the	value	is	not	statistically	significant.	
We	also	recorded	difference	in	the	diastolic	pressure	in	the	
same	period	of	pregnancy.	Statistically	 significant	difference	 is	
obvious	between	the	normotensive	and	hypertensive	pregnancies	
at	the	level	of	p<0,05;	however	there	was	not	difference	between	
the	MP	and	SP.
In	 relation	 to	 the	 calculated	 values	 of	 MAP,	 the	 average	
values	in	the	periods	of	8-12,	13-16	and	17-20	wg.	The	statistical	
difference	between	the	groups	is	obvious	on	a	level	of		p<0,05.	
Cnossen	 SJ.	 Et	 al.(2008),	 worked	 on	 34	 studies	 in	 which	
60599	women	were	observed,	of	which	3341	had	preeclampsia.	
Their	hypothesis	was	based	on	the	diastolic	average,	but	not	on	
the	 systolic	 pressure.	 They	 concluded	 that	 the	 diastolic	 blood	
pressure	over	75mmHg	in	the	period	of	13-20wg	has	predictive	
importance.	They	also	concluded	that	in	the	same	period	the	MAP	
values	over	85-90	mmHg	also	has	predictive	importance	for	the	
development	of	PE,	which	was	also	the	case	in	our	research,	too	
[21].
The	 importance	 of	 the	 regular	 measurement	 of	 the	 blood	
pressure	and	the	MAP	values	was	emphasized by	other	authors,	
too.	Walsh	AC.	and	Baxi	VL.	(2008),	find	out	that	values	of	DBP	
over	 75	 mmHg,	 have	 limited	 predictive	 importance	 for	 pre-
eclampsia,	also	the	MAP	values	in	the	second	quarter	are	better	
predictor	 in	 relation	 to	PE,	 	as	well	as	DBP	and	even	more	on	
SBP	[22].
After	 childbirth,	 blood	 pressure	 between	 groups	 did	 not	
differ.	This	proves	that	the	deliveries	are	only	real	cure	for	pre-
eclampsia.	
At	the	hypertensive	pregnancies	with	an	easier	form	of	PE	
the	hypertension	was	commencing	in	the	period	of	34,5±2,7	wg	
and	it	lasted	in	average	of	4,8±2,6	weeks.	With	the	pregnancies	
with	severe	forms,	PE	was	commencing	around	30,4±4,5wg	and	
lasted	 in	 average	 of	 8.0±4.3	weeks.	Our	 results	 concluded	 the	
same	 facts	 that	 the	 hypertension	 that	 is	manifested	 earlier	 and	
lasts	longer,	affects	the	level	of	unbalance.
With	easier	forms	of	PE,	at	the	largest	part	of	the	pregnancies	
(92,5%)	the	defect	was	manifested	after	31	wg,	while	at	7,46%	
the	unbalance	development	happened	in	the	period	of	26-30	wg.	
At	 the	 severe	 forms	 at	 18,2%	 pregnancies	 the	 unbalance	 was	
developed	before	25	wg,	at	24,2%	in	the	period	of	26-30	wg,	and	
in	57,6%	after	31	wg.
Early	 diagnosis	 of	 PE	 has	 important	 implication	 for	 the	
management	and	prognosis	of	both	the	mother	and	the	fetus.	It	
depends	on	the	accurate	measurement	of	BP,	as	hypertension	is	
often	 the	 only	 early	 sign	 of	 impending	PE.	 It	 is	 not,	 however,	
necessarily	indicative	of	PE	or	indeed	eclampsia	[21]	.
Based	 on	 all	 that	we	 can	 conclude	 that	measuring	 the	BP	
from	the	beginning	of	the	pregnancy	and	knowing	the	values	of	
the	artery	pressure	before	the	conception,	we	can	divide	a	group	
of	pregnancies	that	are	below	the	risk	of	PE.	In	the	period	within	
20	w.g.	the	values	of	MAP	over	85-90mmHg	and	values	of	DBP	
over	75mmHg	are	important	predictive	indicator	for	determination	
the	 risk	 of	 hypertensive	 disorders	 in	 pregnancy,	 especially	 PE	
[23].	To	reduce	the	level	of	prenatal	morbidity	and	mortality	in	
PE,	it’s	necessary	to	insist	on	regular	and	organized	control	for	
every	pregnancy,	because	it	is	proven	that	with	better	antenatal	
protection,	we	can	influence	prenatal	morbidity	and	mortality	[24,	
25].	Screening	for	preeclampsia	with	blood	pressure	measurement	
is	 recommended	 for	 all	 pregnant	 women	 at	 the	 first	 prenatal	
visit	 and	 periodically	 throughout	 the	 remainder	 of	 pregnancy.	 
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The	optimal	frequency	for	measuring	blood	pressure	in	pregnant	
women	has	not	been	determined	and	is	left	to	clinical	discretion	
it	is	most	efficient	to	measure	blood	pressure	on	women	who	are	
being	seen	by	their	clinicians	for	other	reasons.	The	collection	of	
meaningful	blood	pressure	data	requires	consistent	use	of	correct	
technique	and	a	cuff	of	appropriate	size	[26].
Future	 research	 should	 concentrate	 on	 the	 development	 of	
algorithms	 that	 combine	biochemical	 and	biophysical	markers,	
including	 blood	 pressure	 measurement	 –	 a	 diagnostic	 process	
used	 in	 clinical	 care.	 These	 may	 help	 improve	 the	 predictive	
accuracy	of	the	tests	to	clinically	important	values		[8,	24,	26].
An	integrated	first	hospital	visit	at	first	trimester	combining	
data	from	maternal	characteristics	and	history	and	maternal	blood	
pressure	measurement	can	define	the	patient	at	risk	for	PE	[24,	
25].	
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